EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Relação entre transtorno dismórfico corporal e o uso indiscriminado dos agonistas de GLP-1

Laiana da Silva Brito, Luiz Alberto Ferreira Moraes, Loiane Sampaio Portella, Clynio de Araujo Brandão Filho, Isaac de Sá Siqueira, Maria Luiza Andrade Alves, Maria Vitória Figueiredo Barbosa Lima, Dayane Chimendes de Carvalho Lima

Revista ft · 25.06.2026 · 30 (159) · 01-13

DOI: 10.69849/gq96ye58 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista ft, online erschienen am 25.06.2026. Verfasst von Laiana da Silva Brito und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to analyze, based on scientific literature, the possible relationship between body dysmorphic disorder and the indiscriminate use of GLP-1 receptor agonists for aesthetic purposes, investigating the health impacts associated with the misuse of these medications.

Method

This is an integrative literature review of descriptive and exploratory nature. The bibliographic search was conducted in PubMed, SciELO, and LILACS databases. Original and review articles published in the last 10 years, in Portuguese, English, and Spanish, were included. Studies with methodological flaws or that did not address the intersection between mental health and the use of GLP1 agonists were excluded.

Results

Fifteen articles were selected for analysis, published between 2019 and 2025. The findings reveal a significant intersection between the offlabel aesthetic use of GLP-1 agonists, social media influence on beauty standards, and psychiatric vulnerabilities associated with body image distortion. Evidence suggests that unsupervised use of these drugs may intensify dysmorphic symptoms, particularly in young individuals with prior psychiatric history.

Conclusion

The indiscriminate use of GLP-1 receptor agonists for cosmetic purposes represents a significant public health risk, especially for individuals with body dysmorphic disorder. The absence of specific clinical guidelines and psychiatric screening protocols highlights the urgent need for regulatory measures, multidisciplinary approaches, and further research on this emerging topic.

Zitieren

APA

Brito, L. D. S., Moraes, L. A. F., Portella, L. S., Filho, C. D. A. B., Siqueira, I. D. S., Alves, M. L. A., Lima, M. V. F. B., & Lima, D. C. D. C. (2026). Relação entre transtorno dismórfico corporal e o uso indiscriminado dos agonistas de GLP-1. Revista ft, 30(159), 01-13. https://doi.org/10.69849/gq96ye58

Vancouver

Brito LDS, Moraes LAF, Portella LS, Filho CDAB, Siqueira IDS, Alves MLA, et al. Relação entre transtorno dismórfico corporal e o uso indiscriminado dos agonistas de GLP-1. Revista ft. 2026;30(159):01-13. doi:10.69849/gq96ye58

BibTeX
@article{Brito2026,
  author = {Brito, Laiana da Silva and Moraes, Luiz Alberto Ferreira and Portella, Loiane Sampaio and Filho, Clynio de Araujo Brandão and Siqueira, Isaac de Sá and Alves, Maria Luiza Andrade and Lima, Maria Vitória Figueiredo Barbosa and Lima, Dayane Chimendes de Carvalho},
  title = {Relação entre transtorno dismórfico corporal e o uso indiscriminado dos agonistas de GLP-1},
  journal = {Revista ft},
  year = {2026},
  volume = {30},
  number = {159},
  pages = {01--13},
  doi = {10.69849/gq96ye58}
}
Kostenlos starten →